Total Payments
$280,481
2024 Payments
$26,554
Companies
19
Transactions
321
Medicare Patients
5,371
Medicare Billing
$384,431
Payment Breakdown by Category
Other$260,057 (92.7%)
Travel$8,537 (3.0%)
Food & Beverage$7,243 (2.6%)
Consulting$4,620 (1.6%)
Education$24.37 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $260,057 | 116 | 92.7% |
| Travel and Lodging | $8,537 | 58 | 3.0% |
| Food and Beverage | $7,243 | 142 | 2.6% |
| Consulting Fee | $4,620 | 2 | 1.6% |
| Education | $24.37 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $119,349 | 132 | $0 (2024) |
| Amarin Pharma Inc. | $44,061 | 44 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $42,479 | 51 | $0 (2024) |
| Esperion Therapeutics, Inc. | $25,460 | 21 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $21,519 | 16 | $0 (2019) |
| Kaneka Pharma America LLC | $12,588 | 3 | $0 (2021) |
| PFIZER INC. | $9,255 | 17 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $3,357 | 13 | $0 (2024) |
| Akcea Therapeutics, Inc. | $1,820 | 1 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $142.67 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,554 | 30 | Amgen Inc. ($13,485) |
| 2023 | $33,322 | 36 | Amgen Inc. ($22,139) |
| 2022 | $27,153 | 21 | Regeneron Healthcare Solutions, Inc. ($8,986) |
| 2021 | $42,358 | 28 | Amgen Inc. ($18,815) |
| 2020 | $27,219 | 20 | Amgen Inc. ($9,689) |
| 2019 | $40,326 | 55 | Amarin Pharma Inc. ($20,293) |
| 2018 | $40,125 | 61 | SANOFI-AVENTIS U.S. LLC ($13,992) |
| 2017 | $43,424 | 70 | Amgen Inc. ($16,045) |
All Payment Transactions
321 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Cardiology | ||||||
| 09/24/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 09/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $109.65 | General |
| Category: Cardiology | ||||||
| 08/27/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $381.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 07/22/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Travel and Lodging | In-kind items and services | $396.64 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 07/22/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/18/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Travel and Lodging | In-kind items and services | $150.08 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/18/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Travel and Lodging | In-kind items and services | $21.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/12/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $830.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/06/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,088.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 05/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $132.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/24/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Travel and Lodging | In-kind items and services | $261.71 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 05/23/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $115.83 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 05/16/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,566.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 05/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $103.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/10/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $77.77 | General |
| 05/01/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $41.15 | General |
| Category: Cardiology | ||||||
| 05/01/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Cardiology | ||||||
| 04/30/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $250.58 | General |
| Category: Cardiology | ||||||
| 04/25/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 04/25/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 04/25/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $467.00 | General |
| Category: Cardiology | ||||||
| 04/12/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | In-kind items and services | $305.24 | General |
| Category: Cardiology | ||||||
| 04/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Cardiology | ||||||
| 04/11/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | In-kind items and services | $260.00 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,386 | 1,575 | $301,924 | $98,768 |
| 2022 | 15 | 1,435 | 1,685 | $326,787 | $107,230 |
| 2021 | 13 | 1,315 | 1,644 | $326,706 | $113,970 |
| 2020 | 10 | 1,235 | 1,382 | $204,117 | $64,463 |
Total Patients
5,371
Total Services
6,286
Medicare Billing
$384,431
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 587 | 677 | $115,098 | $54,324 | 47.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 181 | 185 | $42,550 | $21,613 | 50.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 50 | 50 | $54,500 | $6,889 | 12.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 14 | 14 | $34,440 | $4,324 | 12.6% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 14 | 28 | $6,160 | $3,129 | 50.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 224 | 246 | $21,402 | $2,321 | 10.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 14 | 56 | $7,840 | $2,008 | 25.6% |
| 99451 | Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | Office | 2023 | 50 | 58 | $2,320 | $1,524 | 65.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 102 | 105 | $8,400 | $1,378 | 16.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 14 | 14 | $6,062 | $608.27 | 10.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 101 | 104 | $2,392 | $330.63 | 13.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 35 | 38 | $760.00 | $319.20 | 42.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 564 | 700 | $119,000 | $54,349 | 45.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 208 | 210 | $48,300 | $25,357 | 52.5% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 19 | 38 | $8,120 | $6,408 | 78.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 19 | 19 | $46,740 | $5,682 | 12.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 42 | 42 | $45,780 | $5,175 | 11.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 17 | 68 | $9,520 | $3,299 | 34.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 223 | 241 | $20,967 | $2,217 | 10.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 109 | 116 | $9,280 | $1,508 | 16.3% |
| 99451 | Telephone or internet assessment with written report by consulting physician, 5 minutes or more | Office | 2022 | 47 | 53 | $2,120 | $1,462 | 69.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 20 | 20 | $8,660 | $953.84 | 11.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 93 | 98 | $2,254 | $310.70 | 13.8% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2022 | 14 | 14 | $2,212 | $169.48 | 7.7% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2022 | 13 | 14 | $2,590 | $162.97 | 6.3% |
About Dr. James Trippi, MD
Dr. James Trippi, MD is a Internal Medicine healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164488037.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Trippi, MD has received a total of $280,481 in payments from pharmaceutical and medical device companies, with $26,554 received in 2024. These payments were reported across 321 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($260,057).
As a Medicare-enrolled provider, Trippi has provided services to 5,371 Medicare beneficiaries, totaling 6,286 services with total Medicare billing of $384,431. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Indianapolis, IN
- Active Since 04/21/2006
- Last Updated 05/23/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1164488037
Products in Payments
- Repatha (Biological) $119,109
- Vascepa (Drug) $44,061
- EVKEEZA (Biological) $32,395
- NEXLIZET (Drug) $25,335
- PRALUENT (Drug) $21,519
- LIPOSORBER (Device) $12,403
- CHANTIX (Drug) $9,244
- PRALUENT ALIROCUMAB INJECTION (Biological) $9,201
- LEQVIO (Drug) $441.63
- PRALUENT (Biological) $167.32
- Kanuma (Drug) $142.67
- NEXLETOL (Drug) $125.00
- FFRct (Device) $121.95
- ENTRESTO (Drug) $115.71
- ELIQUIS (Drug) $115.42
- Corlanor (Drug) $55.53
- XARELTO (Drug) $51.85
- BRILINTA (Drug) $45.31
- GoNitro (Drug) $42.69
- JUXTAPID (Drug) $30.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Indianapolis
Rafat Abonour, Md, MD
Internal Medicine — Payments: $833,709
Internal Medicine $833,709
David Batt, Md, MD
Internal Medicine — Payments: $682,018
Internal Medicine $682,018
Ashwin Ravichandran, Md, MD
Internal Medicine — Payments: $398,583
Internal Medicine $398,583
John Miller, Md, MD
Internal Medicine — Payments: $325,524
Internal Medicine $325,524
Naga Chalasani, Md, MD
Internal Medicine — Payments: $303,095
Internal Medicine $303,095
Dr. Woodrow Corey, Md, MD
Internal Medicine — Payments: $262,512
Internal Medicine $262,512